Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

MSF protests at International AIDS Conference asking for price reduction for CAB-LA and LEN-LA
Press release
Press release |
30 March 2026
HIV/AIDS

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

MSF doctor Dr. Maham Khalid is examining four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab. Photo Credit: Gul Nayab
Press release
Press release |
24 March 2026
Tuberculosis

MSF demands sustained investments and political will to end neglect of children with tuberculosis

5 min
Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health. Photo credit: MSF/Martim Gray Pereira
Press release
Press release |
19 March 2026
Pandemic preparedness Research and development
European Union

MSF calls on EU to unlock progress in final Pandemic Agreement talks

2 min
"" Photo credit: Mudit Mathur
Press release
Press release |
05 March 2026
Intellectual property and trade
EuropeIndia

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

4 min
Insulin pens, provided by MSF to diabetes type I patients below 15 years old. Photo credit: Jinane Saad/MSF
Press release
Press release |
02 December 2025
Diabetes

MSF responds to Novo Nordisk’s discontinuation of key insulin products in EU/EEA

2 min
Every three minutes, a child dies of tuberculosis (TB), even though treatment is available. In children, under-diagnosis is a major obstacle to effective treatment. New WHO recommendations, including treatment decision algorithms, could change all that. Photo Credit: Stuart Tibaweswa
Press release
Press release |
18 November 2025
Tuberculosis

MSF findings show WHO algorithms could double the number of children diagnosed and treated for TB

5 min
Abu Al-Fadl, a young boy diagnosed early with tuberculosis, sits with his father and an MSF health promoter at Mustafa Al-Adhari Health Center in Sadr City. After completing his treatment, he has recovered and will soon return to school.. Photo Credit: Deniz Fahmi/MSF
Press release
Press release |
12 November 2025
Tuberculosis

MSF responds to WHO’s annual Global TB Report: Governments and donors must close the deadly gap in diagnosing and treating TB in children

3 min
Panel discussion in Brussels on how to improve the availability and affordability of TB medicines in the EU and EEA region. Shailly Gupta/MSF
Press release
Press release |
14 October 2025
Tuberculosis
Europe

MSF urges EU and EEA to put TB back on the health agenda

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury